Menu
GeneBe

17-12020911-G-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2

The NM_003010.4(MAP2K4):c.25G>A(p.Gly9Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000222 in 1,215,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G9R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

MAP2K4
NM_003010.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.34
Variant links:
Genes affected
MAP2K4 (HGNC:6844): (mitogen-activated protein kinase kinase 4) This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant where missense usually causes diseases, MAP2K4
BP4
Computational evidence support a benign effect (MetaRNN=0.21197313).
BS2
High AC in GnomAd at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP2K4NM_003010.4 linkuse as main transcriptc.25G>A p.Gly9Ser missense_variant 1/11 ENST00000353533.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP2K4ENST00000353533.10 linkuse as main transcriptc.25G>A p.Gly9Ser missense_variant 1/111 NM_003010.4 P2P45985-1
ENST00000579522.1 linkuse as main transcriptn.186+412C>T intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151838
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000197
AC:
21
AN:
1063756
Hom.:
0
Cov.:
32
AF XY:
0.0000219
AC XY:
11
AN XY:
502458
show subpopulations
Gnomad4 AFR exome
AF:
0.0000450
Gnomad4 AMR exome
AF:
0.000256
Gnomad4 ASJ exome
AF:
0.000815
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000769
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151838
Hom.:
0
Cov.:
33
AF XY:
0.0000539
AC XY:
4
AN XY:
74172
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000295
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000604

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 07, 2022The c.25G>A (p.G9S) alteration is located in exon 1 (coding exon 1) of the MAP2K4 gene. This alteration results from a G to A substitution at nucleotide position 25, causing the glycine (G) at amino acid position 9 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Uncertain
0.064
T
BayesDel_noAF
Benign
-0.15
Cadd
Benign
23
Dann
Uncertain
0.98
DEOGEN2
Benign
0.27
T;.
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.70
T;T
M_CAP
Pathogenic
0.59
D
MetaRNN
Benign
0.21
T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
-0.14
N;N
MutationTaster
Benign
0.57
N;N
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
0.24
N;N
REVEL
Benign
0.17
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;D
Vest4
0.40
MutPred
0.24
Gain of glycosylation at G9 (P = 0.0017);Gain of glycosylation at G9 (P = 0.0017);
MVP
0.94
MPC
1.2
ClinPred
0.51
D
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.9
Varity_R
0.10
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs959911955; hg19: chr17-11924228; COSMIC: COSV62260498; COSMIC: COSV62260498; API